2. Recent Advances in Acute and Fulminant Hepatitis in Japan

Internal Medicine

Volumn 40, Issue 2, 2001, Pages 175-177

  Mochida, Satoshi ^a   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute hepatitis; Fulminant hepatitis; Late onset liver failure; Liver transplantation; Massive liver necrosis

Indexed keywords

ANTICOAGULANT AGENT;

ACUTE DISEASE; ANIMAL; COMPARATIVE STUDY; HEPATIC ENCEPHALOPATHY; HUMAN; IMMUNOLOGY; JAPAN; LIVER TRANSPLANTATION; MULTIMODALITY CANCER THERAPY; NECROSIS; PATHOLOGY; PLASMAPHERESIS; PROGNOSIS; PROSPECTIVE STUDY; RAT; RENAL REPLACEMENT THERAPY; REVIEW; SUPERINFECTION; SURVIVAL RATE; THROMBOCYTOSIS; VIRUS HEPATITIS;

ACUTE DISEASE; ANIMALS; ANTICOAGULANTS; COMBINED MODALITY THERAPY; HEPATIC ENCEPHALOPATHY; HEPATITIS, VIRAL, HUMAN; HUMANS; JAPAN; LIVER TRANSPLANTATION; NECROSIS; PLASMA EXCHANGE; PROGNOSIS; PROSPECTIVE STUDIES; RATS; RENAL DIALYSIS; SUPERINFECTION; SURVIVAL RATE; THROMBOCYTOSIS;

EID: 0035257477     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.175     Document Type: Article

References (25)

1. Yano M. Sporadic acute hepatitis. KAN ·TAN · SUI 39: 173-178, 1999.
2. Okamoto H, Nishizawa T, Kato N, et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatology Res 10: 1-16, 1998.
3. Uchida T, Saitoh T, Shinzawa H. Mutations of the X region of hepatitis B virus and their clinical implications. Pathol Int 47: 183-193, 1997.
4. Sato S, Suzuki S, Takikawa Y. Prospective study to clarify the prognosis of patients with acute hepatitis severe type and fulminant hepatitis in Japan. Intractable Liver Diseases Study Group of Japan, The Ministry of Health and Welfare. Annual Report at 1998, pp 67-69, 1999 (in Japanese).
5. Muto Y. Fulminant hepatitis in Japan (1992). Intractable Liver Diseases Study Group of Japan, The Ministry of Health and Welfare. Annual Report at 1993, pp 44-50, 1994.
6. Ohnishi H, Sugihara J, Moriwaki H, et al. Detection of anti-hepatitis C virus antibody in fulminant hepatic failure. Gastroenterol Jpn 26 Suppl 3: 212-215, 1991.
7. Omata M, Ehata T, Yokosuka O, et al. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 324: 1699-1704, 1991.
8. Nishizawa T, Okamoto H, Tsuda F, et al. Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virology 73: 9604-9608, 1999.
9. Ando K, Hiroishi K, Kaneko T, et al. Perforin, Fas/Fas ligand, and TNF-α pathway as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158: 5283-5291, 1997.
10. Yamada S, Ogata I, Hirata K, et al. Intravascular coagulation in the development of massive hepatic necrosis induced by Corynebacterium parvum and endotoxin in rats. Scand J Gastroenterol 24: 293-298, 1989.
11. Mochida S, Ogata I, Hirata K, et al. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 99: 771-777, 1990.
12. Toshima K, Mochida S, Ishikawa K, et al. Contribution of CD14 to endotoxin-induced liver injury may depend on types of macrophage activation in rats. Biochem Biophys Res Commun 246: 731-735, 1998.
13. Kawashima R, Mochida S, Matsui A, et al. Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: A possible factor for macrophage migration into hepatic necrotic areas. Biochem Biophys Res Commun 256: 527-531, 1999.
14. Wang YH, Mochida S, Kawashima R, et al. Increased expression of osteopontin in activated Kupffer cells and hepatic macrophages during macrophage migration in Propionibacterium acnes-treated rat liver. J Gastreoenterol 2000 (in press).
15. Mochida S, Ogata I, Ohta Y, et al. In situ evaluation of the stimulatory state of hepatic macrophages based on their ability to produce superoxide anions in rats. J Pathol 158: 67-71, 1989.
16. Arai M, Mochida S, Ohno A, et al. Sinusoidal endothelial cell damage by activated hepatic macrophages in rat liver necrosis. Gastroenterology 104: 1466-1471, 1993.
17. Mochida S, Ohno A, Arai M, et al. Role of adhesion molecules in the development of massive hepatic necrosis in rats. Hepatology 23: 320-328, 1996.
18. Mochida S, Ohta Y, Ogata I, et al. Gut-derived substances in activation of hepatic macrophages after partial hepatectomy in rats. J Hepatol 16: 266-272, 1992.
19. Arai M, Mochida S, Ohno A, et al. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: Evaluation with rat models. Hepatology 27: 123-127, 1998.
20. Mochida S, Arai M, Ohno A, et al. Deranged blood coagulation equilibrium as a factor of massive liver necrosis following endotoxin administration in partially hepatectomized rats. Hepatology 29: 1532-1540, 1999.
21. Fujiwara K, Mochida S, Matsui A. Fulminant hepatitis and late onset hepatic failure in Japan (1998). Intractable Liver Diseases Study Group of Japan, The Ministry of Health and Welfare. Annual Report at 1999, 2000.
22. Ishiki Y, Sugihara J, Naito T, et al. Guideline of liver transplantation for fulminant hepatitis. Acta Hepatologica Jpn 73: 760-761, 1996.
23. Sato S, Suzuki K, Takigawa Y. Fulminant hepatitis and late onset hepatic failure in Japan (1998). Intractable Liver Diseases Study Group of Japan, The Ministry of Health and Welfare. Annual Report at 1998, pp 62-66, 1999.
24. Arai M, Mochida S, Ohno A, et al. Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor. Thromb Res 80: 113-123, 1995.
25. Yamanobe F, Mochida S, Ohno A, et al. Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls. Thromb Res 85: 493-501, 1997.